New hope for kids with Hard-to-Control seizures: drug trial launches
NCT ID NCT07594158
First seen May 19, 2026 · Last updated May 21, 2026 · Updated 2 times
Summary
This study tests a medicine called cenobamate (ONO-2017) in 20 Japanese children aged 2 to 17 who have partial onset seizures that are not controlled by current treatments. The goal is to see if the drug is safe and helps reduce seizures. Participants will take the medicine and be monitored for side effects and seizure changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARTIAL EPILEPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Japan Red Cross Fukuoka Hospital
RECRUITINGFukuoka, Japan
Conditions
Explore the condition pages connected to this study.